In collaboration with Exact Sciences, Baylor Scott & White Research Institute are now enrolling its first patients in the Texas Multi-Cancer Early Detection (MCED) Registry.
Baylor University Medical Center’s uterus transplant program—the largest of its kind in the world—published the results of an eight-year trial in JAMA, finding the procedure is safe and effective, resulting in a high rate of live births. The seminal study
...
The study results show exciting immune responses in patients with operable esophageal or gastroesophageal cancers given neoadjuvant immunotherapy and highlight the potential for monitoring circulating tumor DNA as a predictor for future intervention.
After more than 18 months of working to meet the criteria to become an authorized treatment center,
Baylor University Medical Center is poised to be one of the first in the nation to offer a newly FDA-approved tumor-infiltrating lymphocytes (TIL) cellula
...
Baylor Scott & White Health, the largest not-for-profit health system in the state of Texas, today announces a new approach to education for employees.
